Topics
- Therapies for MDS
- Current risk stratification models in MDS
- Therapies in CML and MPNs
- The proper initial management of newly diagnosed CML
- Agents and regimens in non-Hodgkin Lymphoma
- Optimal management strategies for diffuse large B cell and follicular lymphomas
- Therapies in the development for multiple myeloma
- Therapeutic options for newly diagnosed multiple myeloma
- Common symptoms related to the treatment of hematologic malignancies
- Treatment options for patients with malignant hematologic diagnoses based on the latest evidence presented
Who should Attend
Medical oncologists, hematologists, fellows, pharmacists, advanced practice professionals, residents, oncology nurses and other healthcare personnel who are interested in this field of Hematologic Malignancies.
